JoelGelernterMD
Psychiatry • West Haven, CTFoundations Fund Professor of Psychiatry; Professor of Genetics and Neuroscience, Yale University School of Medicine; Director, Division of Human Genetics (Psychiatry)
Dr. Gelernter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Avenue
VA CT Healthcare Center 116a2
West Haven, CT 06516Phone+1 203-932-5711
Summary
- Dr. Joel Gelernter is Professor of Psychiatry at Yale University School of Medicine and is also affiliated with Veterans Affairs Connecticut Healthcare System. He received his medical degree from State University of New York Downstate Medical Center College of Medicine. He does not see patients. He is experienced in genetics, pharmacogenomics, and population genetics.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Psychosomatic Medicine, 1986 - 1988
UPMC Medical EducationResidency, Psychiatry, 1984 - 1986
Stony Brook MedicineInternship, Transitional Year, 1983 - 1984
State University of New York Downstate Medical Center College of MedicineClass of 1983
Certifications & Licensure
CT State Medical License 1988 - 2025
MD State Medical License 1986 - 1988
PA State Medical License 1984 - 1988
NY State Medical License 1984 - 1985- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Genomics of Posttraumatic Stress Disorder in Veterans Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 1 citationsConcerns about genetic risk testing for opioid use disorder.Alexander S Hatoum, Christal N Davis, Rachel L Kember, Mandy Johnstone, David W Oslin
The Lancet. Psychiatry. 2025-02-01 - A semi-empirical Bayes approach for calibrating weak instrumental bias in sex-specific Mendelian randomization studies.Yu-Jyun Huang, Nuzulul Kurniansyah, Daniel F Levey, Joel Gelernter, Jennifer E Huffman
Medrxiv. 2025-01-02 - Utility of Candidate Genes From an Algorithm Designed to Predict Genetic Risk for Opioid Use Disorder.Christal N Davis, Zeal Jinwala, Alexander S Hatoum, Sylvanus Toikumo, Arpana Agrawal
JAMA Network Open. 2025-01-02
Journal Articles
- Methylation in OTX2 and Related Genes, Maltreatment, and Depression in ChildrenJames Hudziak, Joan Kaufman, Eric J Nestler, Joel Gelernter, Robert Althoff, Stewart Mostofsky, Nature
- Genome‐Wide Association Meta‐Analysis of Age at First Cannabis UseHenry R Kranzler, Joel Gelernter, Tamara L Wall, Addiction
- AUDIT‐C and ICD Codes as Phenotypes for Harmful Alcohol Use: Association with ADH1B Polymorphisms in Two U.S. PopulationsDavid A Fiellin, William C Becker, Joel Gelernter, Henry R Kranzler, Ning Sun, John Concato, Addiction
- Join now to see all
Authored Content
- GWAS of Lifetime Cannabis Use Reveals New Risk Loci, Genetic Overlap with Psychiatric Traits, and a Causal Influence of SchizophreniaAugust 2018
- GWAS of Lifetime Cannabis Use Reveals New Risk Loci, Genetic Overlap with Psychiatric Traits, and a Causal Influence of SchizophreniaAugust 2018
- F131. Genome-Wide Association Study Identifies Glutamate Ionotropic Receptor GRIA4 as a Risk Gene for Comorbid Nicotine Dependence and Major DepressionApril 2018
- Genome-Wide Association Study Identifies a Regulatory Variant of RGMA Associated with Opioid Dependence in European AmericansJanuary 2018
- Join now to see all
Press Mentions
Anxiety: Genetic Predisposition DiscoveredSeptember 21st, 2024- Multiple Substance Use Disorders May Share Inherited Genetic SignatureMarch 22nd, 2023
- Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use DisordersJuly 26th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
